A groundbreaking new venture, ENDSULIN, is unlocking new gene therapy techniques to free patients from the daily burdens of today’s taxing diabetes treatments.
Dr. Hans Sollinger and Dr. Tausif Alam have invented a patented DNA sequence (called GIRE) that can help the body regulate insulin on its own. Now, their team is working to develop the discovery into a durable cure that could reach millions of diabetes patients.
This advancement could revolutionize the way we treat diabetes.
The GIRE reprograms a fraction of the hepatocytes in the liver to regulate insulin release precisely depending on blood glucose levels. The results could be long-lasting with just 1 treatment.
The research is promising, and ENDSULIN is conducting the first-ever pilot study in large, naturally diabetic dogs.